Ihr werdet kaum was günstigeres finden als diese Aktie ....
Sieht aus als würde Cipher wieder im grünen bereich starten .
http://finance.yahoo.com/q?s=dnd.toCipher ist Schuldenfrei und ist schon fast Profitabel dank Lipofen (cholesterinsenker) das schon in USA und Kanada zugelassen ist !!!
Letzte Quartalszahlen
http://finance.yahoo.com/news/...009-cnw-1063492544.html?x=0&.v=1
§ Q3 2009 Summary
§ ---------------
§ - Total revenue increased 59% to $1.1 million, compared with $0.7
§ million in Q3 2008.
§ - Continued steady growth of Lipofen(R) prescriptions.
§ - Commenced CIP-ISOTRETINOIN Phase III safety trial.
§ - A strong balance sheet at quarter end with cash of $9.3 million and
§ no debt.
"The third quarter saw us deliver a solid year-over-year increase in revenue from Lipofen(R) and enroll our first patient in the phase III safety trial for CIP-ISOTRETINOIN, reaching an important clinical milestone for this product after significant trial planning and preparation," said Larry Andrews, President and CEO of Cipher. "Patient enrollment in the CIP-ISOTRETINOIN trial is progressing well and we are also encouraged by Kowa's increased sales and promotion efforts for Lipofen(R), which should drive continued prescription growth for the product."